In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein
Since its inception, SARS-CoV-2 has crossed all borders and continues rampaging around the globe, causing profound economic damage and heavy burden on the scientific community and the healthcare fraternity and facilities. With the emergence of new variants, the global pandemic has prolonged and rais...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier Ltd
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |